
Indian authorities seize J&J Baby Powder in response to Reuters report
pharmafile | December 19, 2018 | News story | Research and Development | Cancer, India, J&J, JJ, asbestos, baby powder, regulation
Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after Reuter’s revealed that the American firm had known its products contained cancer-causing asbestos since the 1970s.
India’s Central Drugs Standard Control Organization (CDSCO) took samples from samples from the firms Baddi plant in the state of Himachal Pradesh late on Tuesday.
Regional drug officer for the southern state of Telangana, Surendranath Sai said on Wednesday that he had also instructed officers to seize samples.
“On the basis of the news report, we are alerting staff to pick up samples. We will test them in a drug control lab here,” Said said to reuters. “We will take action accordingly. Certainly we are worried because millions of babies may be affected.”
The action comes after a Reuters’ investigation revealed that J&J had covered up reports that their Baby Powder contained asbestos since 1971.
In response J&J said that “Reuters article is one-sided, false and inflammatory,” as the company declared that “Johnson & Johnson’s baby powder is safe and asbestos-free.”
Louis Goss
Related Content

Central nervous system cancer metastases – the evolution of diagnostics and treatment
The current forms of immunotherapy, how T cell therapy works and what the future holds

BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design
BioMed X and Servier have announced the launch of Europe’s first XSeed Labs research project, …

T-cell therapy – the evolution of cancer treatments
The current forms of immunotherapy, how T cell therapy works and what the future holds






